Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study

医学 肿瘤科 癌症 内科学 危险系数 比例危险模型 头颈部癌 癌症分期 阶段(地层学) 队列 置信区间 生物 古生物学
作者
Brian O’Sullivan,Shao Hui Huang,Jie Su,Adam S. Garden,Erich M. Sturgis,Li Xu,Nancy Y. Lee,Nadeem Riaz,Xin Pei,Shlomo A. Koyfman,David J. Adelstein,Brian B. Burkey,Jeppe Friborg,Claus Andrup Kristensen,Anita Gothelf,Frank Hoebers,B. Kremer,Ernst‐Jan M. Speel,Daniel W. Bowles,David Raben,Sana D. Karam,Eugene Yu,Wei Xu
出处
期刊:Lancet Oncology [Elsevier BV]
卷期号:17 (4): 440-451 被引量:631
标识
DOI:10.1016/s1470-2045(15)00560-4
摘要

Human papillomavirus-related (HPV+) oropharyngeal cancer is a rapidly emerging disease with generally good prognosis. Many prognostic algorithms for oropharyngeal cancer incorporate HPV status as a stratification factor, rather than recognising the uniqueness of HPV+ disease. The International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S) aimed to develop a TNM classification specific to HPV+ oropharyngeal cancer.The ICON-S study included patients with non-metastatic oropharyngeal cancer from seven cancer centres located across Europe and North America; one centre comprised the training cohort and six formed the validation cohorts. We ascertained patients' HPV status with p16 staining or in-situ hybridisation. We compared overall survival at 5 years between training and validation cohorts according to 7th edition TNM classifications and HPV status. We used recursive partitioning analysis (RPA) and adjusted hazard ratio (AHR) modelling methods to derive new staging classifications for HPV+ oropharyngeal cancer. Recent hypotheses concerning the effect of lower neck lymph nodes and number of lymph nodes were also investigated in an exploratory training cohort to assess relevance within the ICON-S classification.Of 1907 patients with HPV+ oropharyngeal cancer, 661 (35%) were recruited at the training centre and 1246 (65%) were enrolled at the validation centres. 5-year overall survival was similar for 7th edition TNM stage I, II, III, and IVA (respectively; 88% [95% CI 74-100]; 82% [71-95]; 84% [79-89]; and 81% [79-83]; global p=0·25) but was lower for stage IVB (60% [53-68]; p<0·0001). 5-year overall survival did not differ among N0 (80% [95% CI 73-87]), N1-N2a (87% [83-90]), and N2b (83% [80-86]) subsets, but was significantly lower for those with N3 disease (59% [51-69]; p<0·0001). Stage classifications derived by RPA and AHR models were ranked according to survival performance, and AHR-New was ranked first, followed by AHR-Orig, RPA, and 7th edition TNM. AHR-New was selected as the proposed ICON-S stage classification. Because 5-year overall survival was similar for patients classed as T4a and T4b, T4 is no longer subdivided in the re-termed ICON-S T categories. Since 5-year overall survival was similar among N1, N2a, and N2b, we re-termed the 7th edition N categories as follows: ICON-S N0, no lymph nodes; ICON-S N1, ipsilateral lymph nodes; ICON-S N2, bilateral or contralateral lymph nodes; and ICON-S N3, lymph nodes larger than 6 cm. This resembles the N classification of nasopharyngeal carcinoma but without a lower neck lymph node variable. The proposed ICON-S classification is stage I (T1-T2N0-N1), stage II (T1-T2N2 or T3N0-N2), and stage III (T4 or N3). Metastatic disease (M1) is classified as ICON-S stage IV. In an exploratory training cohort (n=702), lower lymph node neck involvement had a significant effect on survival in ICON-S stage III but had no effect in ICON-S stage I and II and was not significant as an independent factor. Overall survival was similar for patients with fewer than five lymph nodes and those with five or more lymph nodes, within all ICON-S stages.Our proposed ICON-S staging system for HPV+ oropharyngeal cancer is suitable for the 8th edition of the Union for International Cancer Control/American Joint Committee on Cancer TNM classification. Future work is needed to ascertain whether T and N categories should be further refined and whether non-anatomical factors might augment the full classification.None.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ther发布了新的文献求助10
1秒前
哈哈哈完成签到,获得积分10
2秒前
4秒前
诚心的初露完成签到,获得积分10
4秒前
lyb完成签到 ,获得积分10
6秒前
风中方盒完成签到,获得积分20
6秒前
布丁圆团完成签到,获得积分10
7秒前
yikeshu完成签到,获得积分10
7秒前
Zoe完成签到 ,获得积分10
8秒前
10秒前
星辰大海应助do0采纳,获得10
11秒前
tt完成签到 ,获得积分10
12秒前
浅辰完成签到,获得积分10
13秒前
大气萤完成签到,获得积分20
14秒前
14秒前
我ppp完成签到 ,获得积分10
14秒前
15秒前
易燃物品完成签到,获得积分10
15秒前
Hello应助Ther采纳,获得10
17秒前
CherylZhao完成签到,获得积分10
18秒前
Galato发布了新的文献求助10
19秒前
颜愫完成签到,获得积分10
19秒前
安详向日葵完成签到 ,获得积分10
20秒前
拼搏的白云完成签到,获得积分10
20秒前
852应助hhh采纳,获得10
20秒前
李白白白完成签到,获得积分10
20秒前
王手完成签到,获得积分10
20秒前
21秒前
一人完成签到,获得积分10
22秒前
do0完成签到,获得积分10
23秒前
yar应助xlz110采纳,获得10
23秒前
NexusExplorer应助落寞凌波采纳,获得10
25秒前
量子星尘发布了新的文献求助10
28秒前
123完成签到 ,获得积分10
28秒前
哈哈呵完成签到,获得积分10
28秒前
28秒前
Rylee完成签到,获得积分10
28秒前
Jiro完成签到,获得积分10
30秒前
我ppp发布了新的文献求助60
31秒前
32秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038368
求助须知:如何正确求助?哪些是违规求助? 3576068
关于积分的说明 11374313
捐赠科研通 3305780
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029